6.ALPHA.,9-DIFLUORO-17-((FLUOROMETHOXY)CARBONOTHIOYL)-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXOANDROSTA-1,4-DIEN-17.ALPHA.-YL PROPANOATE
UNII CC8AR5RHS2
Substance Identification & Data
This profile provides standardized clinical and technical data for 6.alpha.,9-difluoro-17-((fluoromethoxy)carbonothioyl)-11.beta.-hydroxy-16.alpha.-methyl-3-oxoandrosta-1,4-dien-17.alpha.-yl Propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CC8AR5RHS2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H31F3O5S DDOJYRCALRCAOK-CENSZEJFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6.alpha.,9-difluoro-17-((fluoromethoxy)carbonothioyl)-11.beta.-hydroxy-16.alpha.-methyl-3-oxoandrosta-1,4-dien-17.alpha.-yl Propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.